Cargando…

An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids

Mucormycosis is a rare opportunistic fungal infection with a high degree of morbidity and mortality. It classically presents with rapidly progressing, necrotic rhinocerebral mucocutaneous lesions in the setting of an immunocompromised host, especially with concomitant uncontrolled diabetes. We repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Froes, Chadley, Gellatly, Matthew, Watson, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356193/
https://www.ncbi.nlm.nih.gov/pubmed/35942258
http://dx.doi.org/10.1016/j.idcr.2022.e01589
_version_ 1784763463050985472
author Froes, Chadley
Gellatly, Matthew
Watson, Brian
author_facet Froes, Chadley
Gellatly, Matthew
Watson, Brian
author_sort Froes, Chadley
collection PubMed
description Mucormycosis is a rare opportunistic fungal infection with a high degree of morbidity and mortality. It classically presents with rapidly progressing, necrotic rhinocerebral mucocutaneous lesions in the setting of an immunocompromised host, especially with concomitant uncontrolled diabetes. We report the case of a 67-year-old man with well-controlled non-insulin dependent diabetes and brief steroid exposure who presented in sepsis with a tender posterior shoulder skin lesion. The initial lesion enlarged and progressed over several days, developing central areas of ecchymosis and bullae, with several other large lesions appearing at various distant sites. He also experienced an array of systemic symptoms, including fever, malaise, weakness, and acute encephalopathy. A diagnosis of mucor was made by histopathological examination of the initial skin lesion. Despite initiation of amphotericin B and aggressive surgical debridement including transfer to specialist tertiary burn center, the patient passed away less than a week after definitive diagnosis. This is a unique case of disseminated mucormycosis given his lack of chronic immunosuppression or uncontrolled diabetes, and with no risk factors for inoculation except for pacemaker placement 2 months prior to admission. The case highlights the importance of considering mucormycosis in the early differential diagnosis of rapidly progressing skin lesions, as rapid detection and treatment is critical to mitigate the deadly effects of this fast-moving fatal fungus. Moreover, the case serves as a testament to the unpredictable progression of disseminated disease, while also demonstrating an unusual potential mode of introduction and a rare but fatal consequence of prescribing corticosteroids in an infected host.
format Online
Article
Text
id pubmed-9356193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93561932022-08-07 An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids Froes, Chadley Gellatly, Matthew Watson, Brian IDCases Case Report Mucormycosis is a rare opportunistic fungal infection with a high degree of morbidity and mortality. It classically presents with rapidly progressing, necrotic rhinocerebral mucocutaneous lesions in the setting of an immunocompromised host, especially with concomitant uncontrolled diabetes. We report the case of a 67-year-old man with well-controlled non-insulin dependent diabetes and brief steroid exposure who presented in sepsis with a tender posterior shoulder skin lesion. The initial lesion enlarged and progressed over several days, developing central areas of ecchymosis and bullae, with several other large lesions appearing at various distant sites. He also experienced an array of systemic symptoms, including fever, malaise, weakness, and acute encephalopathy. A diagnosis of mucor was made by histopathological examination of the initial skin lesion. Despite initiation of amphotericin B and aggressive surgical debridement including transfer to specialist tertiary burn center, the patient passed away less than a week after definitive diagnosis. This is a unique case of disseminated mucormycosis given his lack of chronic immunosuppression or uncontrolled diabetes, and with no risk factors for inoculation except for pacemaker placement 2 months prior to admission. The case highlights the importance of considering mucormycosis in the early differential diagnosis of rapidly progressing skin lesions, as rapid detection and treatment is critical to mitigate the deadly effects of this fast-moving fatal fungus. Moreover, the case serves as a testament to the unpredictable progression of disseminated disease, while also demonstrating an unusual potential mode of introduction and a rare but fatal consequence of prescribing corticosteroids in an infected host. Elsevier 2022-07-27 /pmc/articles/PMC9356193/ /pubmed/35942258 http://dx.doi.org/10.1016/j.idcr.2022.e01589 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Froes, Chadley
Gellatly, Matthew
Watson, Brian
An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title_full An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title_fullStr An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title_full_unstemmed An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title_short An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
title_sort unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356193/
https://www.ncbi.nlm.nih.gov/pubmed/35942258
http://dx.doi.org/10.1016/j.idcr.2022.e01589
work_keys_str_mv AT froeschadley anunexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids
AT gellatlymatthew anunexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids
AT watsonbrian anunexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids
AT froeschadley unexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids
AT gellatlymatthew unexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids
AT watsonbrian unexpectedcaseofdisseminatedmucormycosisfollowingpacemakerplacementandbriefcourseoforalcorticosteroids